ASCL1 and neuroendocrine neoplasm: Studies have shown that increased ASCL1 expression in gastrointestinal-derived neuroendocrine neoplasms is detected mainly in high-malignancy carcinomas rather than in slower-progressing GEP-NETs, and at a lower frequency compared to lung neuroendocrine carcinomas [34,35].